Tekton is expanding to Houston, TX, with the addition of Lawrence D. Ginsberg, MD. Dr. Ginsberg will lead adult and pediatric psychiatry studies as a Principal Investigator from his clinic, Red Oak Psychiatry Associates. This marks Tekton’s first research location in Houston. Dr. Ginsberg has practiced psychiatry since 1985 and has served as president and … Read more
Andrew H. Martin, MD, psychiatrist and founder of Texas Family Psychiatry, will expand Tekton’s psychiatry research capabilities in San Antonio. Tekton is pleased to welcome Andrew H. Martin, MD, as a Principal Investigator at its San Antonio dedicated research center. Dr. Martin is a psychiatrist with more than 20 years of clinical experience treating children, … Read more
As CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution AUSTIN, TX – May 6, 2026 — Tekton Research, a leading multi-site clinical trial organization with 25 research sites across North America, today announced the appointment of Amit Vijapura, MD as a Central Nervous System (CNS) Key Opinion Leader (KOL), further strengthening … Read more
CNS (central nervous system) trials are some of the most complex–and most meaningful–studies in clinical research today. A recent Society for Clinical Research Sites (SCRS) SCRS Talks episode featuring Tekton’s Jeffrey Zucker and Brandon Lenfest explored the realities of conducting CNS trials—from patient identification to caregiver impact. In this article, we revisit the most compelling moments from that discussion and … Read more
Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that typically develops in early childhood and often leads to lifelong challenges. LGS evolves over time, most commonly emerging between ages 1 and 8. While rare, it affects approximately one in every 2,000 individuals (source: LGS Foundation), with about 50,000 people in the United States and … Read more
Alzheimer’s Disease remains one of the most pressing public health challenges of our time. Affecting over 6 million Americans, this progressive neurological disorder not only takes a profound toll on individuals and their families–it also places a significant burden on healthcare systems worldwide. While there is no cure yet, hope is on the horizon–and clinical … Read more
Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director of Community and Long-Term Care … Read more
Marlboro, NJ – Tekton Research is pleased to announce that Amor R. Mehta, MD, a leading neurologist specializing in epilepsy, seizure disorders and neurodegenerative diseases, has joined the organization’s collaborative network. With a strong commitment to advancing epilepsy care and epilepsy-related neurodiagnostics in New Jersey, Dr. Mehta brings an unparalleled dedication to enhancing patient outcomes … Read more
Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive … Read more
Source: American Migraine Foundation How to navigate school, friends, sports and home life when you have a child with migraine The impact of migraine on a child’s quality of life has been well-documented. Emotional issues and school performance are among the most common problems. Kids often don’t tell others about their migraine, including teachers … Read more